Product Description
| Cat Number | PI-290 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | PACE4 inhibitor |
| Modification | N terminal acetyl, C terminal amide |
| Purity | >95% by hplc |
| Biomarker Target | Serine proteases |
| Sequence Three Letter Code | Ac-Leu-Leu-Leu-Leu-Arg-Val-Lys-Arg-NH2 |
| Molecular Formula | C49H94N16O9 |
| Sl Sequence | Ac-LLLLRVKR-NH2 |
| Solubility | Soluble in water |
| Appearance | Freeze dried solid |
| Storage | Store dry, frozen and in the dark |
| References |
Levesque et al (2012) The Multi-Leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cells. J Med Chem. 55(23) 10501 PMID: 23126600Kwiatkowska et al (2019) Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrug. Sci Rep. 9(1) 2118 PMID: 30765725 Related areas All peptides >All serine protease modulators >All cancer research categories > |
| Note | The product is for research use only |
Share Item: